# Pro-Med

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pro-med

- Industry: Medical Devices & Equipment
- Headquarters: Linz, Austria
- Website: www.smartdose.com
- Total disclosed funding: $3.6M
- Latest round: Series B (Jun 1, 2004)
- Investors on record: 3

## About

Pro-Med focuses on developing innovative drug delivery systems, particularly the SmartDose® On-Body Delivery System, facilitating efficient self-administration of medications for patients.Founded in 1997 in Linz, Austria, Pro-Med specializes in drug delivery solutions. The founder, Enrico Armiento, has a history of innovation in healthcare technology. The company raised EUR 3 million in a Series B funding round in June 2004 from GCP Gamma Capital Partners and Sofinnova Partners, marking its second deal.Pro-Med specializes in the SmartDose® On-Body Delivery System, launched in 2010. This system enables self-administration of medications, particularly for biologics, featuring advanced technologies for precise dosing and improved patient compliance. Pro-Med serves pharmaceutical and biotechnology companies, healthcare providers, and patients globally, particularly in North America, Europe, and select Asia-Pacific regions.Pro-Med generates revenue primarily through B2B contracts with pharmaceutical and biotech firms. Its revenue model includes long-term contracts for the supply of SmartDose® technology and related services, focusing on both one-time sales and ongoing service agreements, reflecting the necessity for continued support in drug delivery.Pro-Med aims to leverage the recent EUR 3 million raised in June 2004 to enhance its product offerings and expand its market presence. The company is working on the next generation of the SmartDose® system, with plans to enter new geographic markets by 2025, specifically targeting regions within Europe and Asia to broaden access to its innovative drug delivery solutions.

## Funding rounds

- Series B, Jun 1, 2004, $3.6M — Sofinnova Partners, GCP Gamma Capital Partners
- Series A, Jun 1, 2002 — Sofinnova Investments

## Investors

- Sofinnova Investments (https://capitalatlas.ai/funds/sofinnova-investments) — Series A
- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Series B
- GCP Gamma Capital Partners (https://capitalatlas.ai/funds/gcp-gamma-capital-partners) — Series B